Chemical Name: (1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(2,3-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Smiles: FC1=C(C=CC=C1F)[C@H]2[C@@H](C2)NC3=C(N=NN4[C@@H]5C[C@H](OCCO)[C@@H](O)[C@H]5O)C4=NC(SCCC)=N3
Inchi: InChI=1S/C23H22F7N4O5P.C7H17NO5/c1-13(14-10-16(22(25,26)27)12-17(11-14)23(28,29)30)39-21(33-6-8-38-9-7-33,15-2-4-18(24)5-3-15)19-31-20(35)34(32-19)40(36)37;1-8-2-4(10)6(12)7(13)5(11)3-9/h2-5,10-13,40H,6-9H2,1H3,(H,36,37)(H,31,32,35);4-13H,2-3H2,1H3/t13?,21-;4-,5+,6+,7+/m00/s1
Estimation Of Ticagrelor In Commercial Dosage Form Using A Sensitive Validated RP-HPLC Method
By Madhuri, K.; Rao, Y. Srinivasa; Varaprasada, Rao K.; Deepthi, R.
From World Journal of Pharmaceutical Research (2021), 10(6), 1281-1292.
Development and validation of stability indicating RP-HPLC method for the estimation of Ticagrelor by forced degradation studies
By Dole, Manjusha; Kendre, Meenakshi; Wagh, Viplav
From World Journal of Pharmacy and Pharmaceutical Sciences (2019), 8(5), 711-724
Development of a validated HPLC-PDA method for stability indicating study of ticagrelor: a novel anti-platelet agent (P2Y12-ADP receptor blocker)
By Sulthana, Shabana; Anuradha, V.; Rao, Mandava V. Basaveswara
From International Journal of Pharmaceutical, Chemical and Biological Sciences (2017), 7(1), 36-42